MoCRA Safety Substantiation for Fragrance: What Evidence Brands Should Keep

Under the Modernization of Cosmetics Regulation Act (MoCRA), fragrance is no longer a simple “black box.” Brands must now hold safety substantiation records for the finished cosmetic product—including the scent components. This guide clarifies…

Category: Fragrance Sourcing Guides • Author: laeyo • Published: 2026-10-16 • Views: 34

Under the Modernization of Cosmetics Regulation Act (MoCRA), fragrance is no longer a simple “black box.” Brands must now hold safety substantiation records for the finished cosmetic product—including the scent components. This guide clarifies exactly what evidence you need to retain for fragrance, how to structure your documentation, and how to stay audit-ready without putting your proprietary blends at risk.

Why Fragrance Safety Substantiation Changed Under MoCRA

Before MoCRA, the FDA did not require cosmetic companies to share safety data or to register their products. Fragrance often appeared as a single line on the label, and the underlying formula was protected as a trade secret. Now, the responsible person (the brand or manufacturer named on the label) must ensure and document that the entire product, fragrance included, is safe for consumers under labeled or customary conditions of use. The law makes no exception for fragrance—its safety must be substantiated, and records must be kept for at least 3 years after the last shipment.

Minimum Evidence Fragrance Brands Should Retain

The FDA expects a “basis” for your safety conclusion. For fragrance, this means you need to keep either the full component list and safety data for each component, or a credible expert safety assessment that covers the entire fragrance blend. The evidence must be robust enough to show you considered all foreseeable risks: skin sensitization, phototoxicity, inhalation exposure for sprays, and potential chronic effects from leave-on products.

1. The Fragrance Component List

  • A complete qualitative and quantitative breakdown of fragrance ingredients (including intentionally added substances and those above the 50‑ppm threshold for reportable fragrance allergens under state laws like California’s).
  • Each ingredient’s CAS number for traceability.
  • Documentation from the fragrance house that lists the allergens present in the finished fragrance oil above 0.001% (leave-on) or 0.01% (rinse-off).

2. Toxicological Summary or Full Safety Assessment

  • A dossier that covers acute toxicity, skin irritation/corrosion, skin sensitization, phototoxicity (if relevant), and any other endpoint flagged by the fragrance’s characteristics.
  • For proprietary blends where the brand doesn’t receive the full formula, a signed safety certificate from a qualified toxicologist or the fragrance supplier is critical. This certificate must state that the blend has been evaluated for its intended use and that applicable safety margins are met.

3. Allergen Risk Assessment

  • A separate evaluation that addresses the 80+ extended fragrance allergens now expected by many retailers and the EU, even if your market is currently US-only. This shows proactive due diligence.
  • Quantitative risk assessment (QRA) or pragmatic margins of safety calculation for skin sensitizers, referencing IFRA Standards concentration limits.

4. Exposure Consideration

  • Evidence that the fragrance concentration in the final product is consistent with the product type (e.g., 0.5‑2% in a face cream vs. 10‑20% in a fine fragrance) and that the exposure scenario matches the assessment.

How to Structure Your Fragrance Safety Dossier

Organize the documentation in a way that an FDA investigator can quickly understand. The table below maps each evidence type to its purpose and retention tip.

Evidence Item Key Purpose What to Retain
Fragrance formula
(quantitative list)
Identify all ingredients for hazard assessment List with CAS numbers, percentages, and allergen highlights; keep supplier correspondence confirming formula currency.
Safety certificate Provide expert conclusion when full data is inaccessible Signed statement from toxicologist/supplier, citing test data or in silico models, with date and product name.
IFRA certificate or compliance statement Demonstrate adherence to industry self-regulation for sensitization Current IFRA Certificate (updated annually), mapped to your product’s category and use level.
Allergen breakdown Meet retailer and emerging regulatory expectations List of 80+ extended allergens with concentrations; if any exceed 0.01% in rinse-off or 0.001% in leave-on, include a risk justification.
Stability & compatibility data Show the scent remains safe over the shelf life Finished product stability testing results (physical, chemical, and olfactory) under intended packaging.
Exposure calculation Confirm safe exposure margins Documented rationale for daily exposure amount (e.g., based on product type, application site, frequency, and retention).

Working with Fragrance Houses: What to Request

Many brands rely on fragrance suppliers for safety data. Requesting a full formula may be impossible, but you can still negotiate for a defensible documentation package:

  • Allergen declaration – extended allergen list with quantitation down to 0.0001%.
  • Safety statement – explicit that the blend meets IFRA Standards and has been assessed for skin sensitization/phototoxicity as applicable.
  • Certificates of analysis (CoA) for each shipment, ensuring batch consistency.
  • Statement of natural/synthetic origin if it’s part of your marketing claims (to avoid later challenges).

Keep all communications as part of your safety substantiation record; the “reasonable reliance” on a supplier’s expertise is acceptable under MoCRA as long as you can produce the documentation.

Common Pitfalls That Can Void Your Substantiation

  • Missing concentration limits: A generic IFRA certificate without your exact product category and use level is not sufficient.
  • Outdated allergen data: Many suppliers still provide only the EU 26 declarable allergens. Under MoCRA, you should already be collecting the extended list.
  • Assuming “natural” means safe: Bergamot oil, citrus extracts, and other naturals can contain phototoxic furocoumarins. Always include specific risk assessments for natural complex substances.
  • No inhalation assessment for sprays: Fine fragrance mists and aerosol deodorants require a lung‑exposure consideration that many brands skip.

Frequently Asked Questions

Can I rely on my fragrance supplier’s IFRA certificate alone?

No. The IFRA certificate shows adherence to industry standards but does not replace a full safety assessment. Under MoCRA, you need a documented conclusion that your finished product, with that fragrance at that concentration, is safe. The IFRA certificate is one piece—you still need the exposure consideration and the overall toxicological evaluation.

What if my fragrance is a proprietary blend and the supplier won’t disclose the formula?

This is common. In that case, obtain a comprehensive safety certificate from the fragrance house or an independent toxicologist, stating the blend has been assessed for its intended use in your product category. The certificate must reference the blend’s internal code, batch traceability, and the safety endpoints reviewed.

How often do I need to update fragrance safety records?

Records must be maintained for 3 years after the last shipment of that formulation. If you reformulate or change the fragrance concentration, a new assessment is required. Additionally, review annual updates to IFRA Standards and allergen regulations to ensure ongoing compliance.

Is the MoCRA safety substantiation requirement the same as FDA registration?

No. Facility registration and product listing are separate administrative steps. Safety substantiation is a pre-market or concurrent requirement; you must have the evidence before you sell the product, and you must keep it ready for inspection.

Ready to compile your fragrance safety dossier or need a toxicological review of your current portfolio? Request a Quote and our regulatory specialists will help you organize the exact evidence package MoCRA demands.

Hi, I'm Alex Zong, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).